ConductScience.org, home

Paper19251722

Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.

Wang Y and 8 others. Cardiovasc Res, 2009. Cited by 140 papers, by iCite.

Cite this record

ConductScience Library. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase. Papers, record 19251722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19251722

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.
PubMed
Journal
Cardiovasc Res
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
140
iCite
Relative citation ratio, by iCite
4.17
iCite
Revised in PubMed
2022-03-09
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang YYiqun
2Huang YYu
3Lam KSKaren S L
4Li YYiming
5Wong WTWing Tak
6Ye HHongying
7Lau CWChi-Wai
8Vanhoutte PMPaul M
9Xu AAimin

Source PubMed

Download CSV of authors

Topics21

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AMP-Activated Protein KinasesMajor topic
BerberineMajor topic
Endothelial CellsMajor topic
HyperglycemiaMajor topic
Nitric Oxide Synthase Type IIIMajor topic
Animals
Aorta
Apoptosis
Cell Adhesion
Cell Line
Enzyme Activation
Humans
Male
Monocytes
NF-kappa B
Nitric Oxide
Rats
Rats, Sprague-Dawley
Reactive Oxygen Species
Signal Transduction
Vasodilation

Source PubMed

Download CSV of topics

Cited by76

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.

PMIDTitleJournalYearIn PapersSource
41901214Self-Assembled Rg3/Naringenin Nanoparticles for Targeted Brain Delivery: A Promising Therapeutic Approach for Early Alzheimer's Disease.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/41901214PubMed
41767379Mechanisms and applications of natural plant ingredients in modulating amino acid metabolism for the improvement of diabetic retinopathy: a review.Front Endocrinol (Lausanne)2026https://conductscience.org/library/papers/41767379PubMed
41596399Berberine: A Negentropic Modulator for Multi-System Coordination.Int J Mol Sci2026https://conductscience.org/library/papers/41596399PubMed
41394126Targeting L-arginine/NO/cGMP/KATP pathway by phytochemicals: therapeutic applications and clinical perspectives.Front Pharmacol2025https://conductscience.org/library/papers/41394126PubMed
41243097Berberine ameliorates high-fat diet-induced metabolic disorders through promoting gut Akkermansia and modulating bile acid metabolism.Chin Med2025https://conductscience.org/library/papers/41243097PubMed
41089338Berberine's impact on health: Comprehensive biological, pharmacological, and nutritional perspectives.Metabol Open2025https://conductscience.org/library/papers/41089338PubMed
40502549A Review of the Mechanisms of Astragaloside IV and Berberine in Vascular Dysfunction Associated with Obesity and Diabetes.Drug Des Devel Ther2025https://conductscience.org/library/papers/40502549PubMed
40192797Levo-corydalmine derived from Rhizoma Corydalis suppresses Ox-LDL-induced endothelial cell activation and improves vasodilatation by regulating the DDIT3-eNOS pathway.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/40192797PubMed
38957396Molecular mechanisms, targets and clinical potential of berberine in regulating metabolism: a review focussing on databases and molecular docking studies.Front Pharmacol2024https://conductscience.org/library/papers/38957396PubMed
38275993A Mechanistic Review on How Berberine Use Combats Diabetes and Related Complications: Molecular, Cellular, and Metabolic Effects.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/38275993PubMed
38034996Efficacy and underlying mechanisms of berberine against lipid metabolic diseases: a review.Front Pharmacol2023https://conductscience.org/library/papers/38034996PubMed
37902881Bioactive molecules from terrestrial and seafood resources in hypertension treatment: focus on molecular mechanisms and targeted therapies.Nat Prod Bioprospect2023https://conductscience.org/library/papers/37902881PubMed
37780378Berberine protects hepatocyte from hypoxia/reoxygenation-induced injury through inhibiting circDNTTIP2.PeerJ2023https://conductscience.org/library/papers/37780378PubMed
37759984AMPK-Dependent YAP Inhibition Mediates the Protective Effect of Metformin against Obesity-Associated Endothelial Dysfunction and Inflammation.Antioxidants (Basel)2023https://conductscience.org/library/papers/37759984PubMed
37298967A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention.Molecules2023https://conductscience.org/library/papers/37298967PubMed
37049878Thermodynamic Parameters of Berberine with Kolliphor Mixtures Adsorption and Micellization.Molecules2023https://conductscience.org/library/papers/37049878PubMed
36094643Potential Therapeutic Activity of Berberine in Thyroid-Associated Ophthalmopathy: Inhibitory Effects on Tissue Remodeling in Orbital Fibroblasts.Invest Ophthalmol Vis Sci2022https://conductscience.org/library/papers/36094643PubMed
35950214Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice.Mol Ther Nucleic Acids2022https://conductscience.org/library/papers/35950214PubMed
35879716Berberine ameliorates mesenteric vascular dysfunction by modulating perivascular adipose tissue in diet-induced obese in rats.BMC Complement Med Ther2022https://conductscience.org/library/papers/35879716PubMed
35784732Berberine Suppresses Lung Metastasis of Cancer via Inhibiting Endothelial Transforming Growth Factor Beta Receptor 1.Front Pharmacol2022https://conductscience.org/library/papers/35784732PubMed

See all 76 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19251722

GET https://conductscience.org/api/papers/v1/19251722/cited_by?page=2